Altimmune raises $75 million to advance pemvidut
Author: Michael
PMD trial ties functional measures with NAD⁺ a
Juvenescence-backed biotech targets ‘continuou
The global autologous cell therapy market—thera
The global autologous cell therapy market—thera
The DUB (deubiquitinase) inhibitors market is exp
Insilico Medicine, a generative artificial intell
Repare Therapeutics Inc.
Bexorg Inc.
Funding to support commercial launch and continu